Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation

INTRODUCTION: To analyze the efficacy of biosimilar ranibizumab compared to innovator ranibizumab and bevacizumab. METHODS: We retrospectively analyzed consecutive patients treated with biosimilar ranibizumab for wet age-related macular degeneration (AMD) and macular edema (ME) (due to diabetes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratra, Dhanashree, Roy, Krishnakanta, Giridhar, Sneha, Madaan, Sushant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770791/
https://www.ncbi.nlm.nih.gov/pubmed/34738211
http://dx.doi.org/10.1007/s40123-021-00416-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770791/
https://www.ncbi.nlm.nih.gov/pubmed/34738211
http://dx.doi.org/10.1007/s40123-021-00416-4

Ejemplares similares